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modeling in physiology
The hot IVGTT two-compartment minimal model:
indexes of glucose effectiveness and insulin sensitivity
PAOLO VICINI,1 ANDREA CAUMO,2 AND CLAUDIO COBELLI1
1Department of Electronics and Informatics, University of Padova, 35131 Padua;
and 2Scientific Institute San Raffaele, 20132 Milan, Italy
Vicini, Paolo, Andrea Caumo, and Claudio Cobelli.
Hot IVGTT two-compartment minimal model: indexes of
glucose effectiveness and insulin sensitivity. Am. J. Physiol.
273 (Endocrinol. Metab. 36): E1024–E1032, 1997.—A two-
compartment minimal model (2CMM) has been proposed [A.
Caumo and C. Cobelli. Am. J. Physiol. 264 (Endocrinol.
Metab. 27): E829–E841, 1993] to describe intravenous glu-
cose tolerance test (IVGTT) labeled (hereafter hot) glucose
kinetics. This model, at variance with the one-compartment
minimal model (1CMM), allows the estimation of a plausible
profile of glucose production. The aim of this study is to show
that the 2CMM also allows the assessment of insulin sensitiv-
ity (SI
2*), glucose effectiveness (SG
2*), and plasma clearance rate
(PCR). The 2CMM was identified on stable-isotope IVGTTs
performed in normal subjects (n 5 14). Results were (means 6
SE) SG
2* 5 0.85 6 0.14 ml·kg21 ·min21, PCR 5 2.02 6 0.14
ml·kg21 ·min21, and SI
2* 5 13.83 6 2.54 3 1022 ml·kg21 ·
min21·µU21·ml. The 1CMM was also identified; glucose effective-
ness and insulin sensitivity indexes were S*GV 5 1.36 6 0.08
ml·kg21 ·min21 and S*IV 5 12.98 6 2.21 3 1022 ml·kg21 ·
min21 ·µU21 ·ml, respectively, where V is the 1CMM glucose
distribution volume. S*GV was lower than PCR and higher
than SG
2* and did not correlate with either [r 5 0.45 (NS) and
r 5 0.50 (NS), respectively], whereas S*IV was not different
from and was correlated with SI
2* (r 5 0.95; P , 0.001). S*G
compares well (r 5 0.78; P , 0.001) with PCR normalized by
the 2CMM total glucose distribution volume. In conclusion,
the 2CMM is a powerful tool to assess glucose metabolism
in vivo.
intravenous glucose tolerance test; tracer kinetics; plasma
clearance rate
THE LABELED (hereafter hot) intravenous glucose toler-
ance test (IVGTT) interpreted with the single-compart-
ment minimal model of hot glucose disappearance
(1CMM) is a powerful, noninvasive tool to characterize
glucose disposal in vivo (1, 7, 10). The model provides
metabolic indexes measuring glucose effectiveness (S*G)
and insulin sensitivity (S*I) in an individual (10). How-
ever, when the model is used in conjunction with
unlabeled (hereafter cold) glucose data to estimate
endogenous glucose production during the IVGTT by
deconvolution, an unphysiological time course results
due to the well-known limitations of the monocompart-
mental representation of glucose kinetics in non-steady
state (7, 8). A two-compartment minimal model (2CMM)
has recently been proposed to solve this problem (8).
The 2CMM provides a physiologically plausible profile
of endogenous glucose production during the test, thus
overcoming the limitations of the 1CMM.
The aim of this study is to show that the new model,
in addition to endogenous glucose release, also provides
indexes of glucose effectiveness and insulin sensitivity.
In particular, the 2CMM overcomes the drawback of
the 1CMM, which is unable to single out estimates of
glucose effectiveness and plasma clearance rate (they
are, in fact, the same parameter, S*G) (7). Thus, in
addition to a new index of insulin sensitivity (SI
2*), the
2CMM provides new indexes separately measuring
glucose effectiveness (SG
2*) and plasma clearance rate at
basal state (PCR). Finally, the relationships between
the indexes estimated with the 1CMM and 2CMM are
elucidated.
THE TWO-COMPARTMENT HOT MINIMAL MODEL
The 2CMM, proposed in Ref. 8 and shown in Fig. 1, is
described, in its uniquely identifiable parameteriza-
tion, by the following equations
q˙1(t) 5 23kp 1 Rd,0Q1 (t) 1 k214q1 (t) 1 k12q2(t)
q1(0) 5 d
(1a)
q˙2(t) 5 k21q1(t) 2 [k02 1 x(t) 1 k12]q2(t) q2(0) 5 0 (1b)
x˙(t) 5 2p25x(t) 2 sk[I(t) 2 Ib]6 x(0) 5 0 (1c)
g(t) 5
q1(t)
V1 (1d)
where q1 and q2 denote hot glucose masses in the first
(accessible pool) and second (slowly equilibrating) com-
partments, respectively (mg/kg for a stable-label
IVGTT); x(t) 5 kcI8(t) is insulin action (min21), where
I8(t) is the concentration of insulin remote from plasma
(µU/ml); I(t) and Ib are plasma insulin and basal (end
test) insulin, respectively (µU/ml); Q1(t) is cold glucose
mass in the accessible pool (mg/kg); g(t) is plasma hot
glucose concentration (mg/dl); d is the hot glucose dose
(mg/kg); V1 is the volume of the accessible pool (ml/kg);
Rd,0 (mg·kg21 ·min21) is the constant component of
glucose disposal (8, 14), accounting for the inhibition of
glucose clearance by glucose itself; kp (min21) is the
proportionality constant; k21 (min21), k12 (min21), and
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k02 (min21) are parameters describing glucose kinetics;
and p2 5 kb (min21) and sk 5 kakc/kb (ml·µU21 ·min21)
are parameters describing insulin action. Capital and
lowercase letters are used to denote variables related to
cold and hot glucose, respectively, and overdot notation
refers to time rates of change for respective variables
[e.g., q˙1(t), q˙2(t), and x˙(t)].
Briefly, the model structure assumes that insulin-
independent glucose disposal takes place in the acces-
sible pool and is the sum of two components, one
constant and the other proportional to glucose mass.
This brings us to the rate constant describing the
irreversible loss from the accessible pool
kp 1
Rd,0
Q1 (t)
5 kp 1
Rd,0
G(t)V1
(2)
where G(t) is the glucose concentration in the accessible
pool of volume V1. It is worth noting that inhibition has
been described by a linearized version, with nonzero
intercept, of the Rd vs. G characteristic, which is
actually of Michaelis-Menten type, where Rd is the rate
of glucose disappearance from the accessible pool. The
two are virtually coincident in the range of IVGTT
glucose concentrations. Therefore, in the 2CMM, any
changes in glucose concentration affect glucose clear-
ance instantaneously. Of course, this may be an oversim-
plification because the dynamics of glucose’s effect on
its own clearance are likely to be more complex, entail-
ing, for instance, a delay between a change in plasma
glucose concentration and the corresponding change in
glucose clearance. However, in the model, we preferred
to keep the description of glucose’s effect on its own
clearance as simple as possible because, to the best of
our knowledge, there are no data in the literature
providing insight into the dynamics of this effect under
non-steady-state conditions.
Insulin-dependent glucose disposal occurs in the
slowly exchanging pool and is assumed to be parametri-
cally controlled, not by plasma, but by insulin in a
remote compartment (13). The interstitial fluid has
been suggested as a possible physiological correlate of
this compartment (4). This brings us to the irreversible
loss from the second compartment
k02 1 x(t) (3)
Arriving at a priori unique identifiability requires two
assumptions. First, we assume that, in the basal steady
state, insulin-independent glucose disposal is three
times insulin-dependent glucose disposal (9). This brings
us to an additional relationship among the model
parameters
kp 1
Rd,0
GbV1
5
3k21k02
k02 1 k12
(4)
where Gb is basal (end test) glucose concentration
(mg/dl). The second assumption is that Rd,0 is fixed to
the experimentally determined value of 1 mg·kg21 ·
min21 (5).
The uniquely identifiable parameterization, as shown
in Ref. 8, is V1, k21, k12, k02, p2, and sk.
DERIVATION OF METABOLIC INDEXES
We show below that the 2CMM provides indexes of
glucose effectiveness and insulin sensitivity. For the
sake of standardization, the two indexes will be derived
in the same units as the corresponding indexes derived
using the glucose-clamp technique; i.e., we will apply
their definitions starting from the Rd vs. G steady-state
characteristic.
Glucose effectiveness. Glucose effectiveness is defined
as the ability of glucose to promote its own disposal. If
one measures glucose disposal by its rate of disappear-
ance from the accessible pool, Rd(t), glucose effective-
ness is then given by the derivative of Rd(t) with respect
to glucose concentration G(t) at basal steady state (SS)
glucose effectiveness 0
­Rd(t)
­G(t) 0ss (5)
The Rd(t) predicted by the model is, by using the
tracer-tracee indistinguishability principle
Rd(t) 5 [kp 1 Rd,0V1G(t) 1 k21 4Q1(t) 2 k12Q2(t) (6)
Thus (see APPENDIX) glucose effectiveness (in ml·kg21 ·
min21) from the 2CMM is
SG
2* 5
­Rd(t)
­G(t) 0ss 5 V1 1kp 1
k21k02
k02 1 k122 (7)
Plasma clearance rate. Another parameter of interest
that can be derived from the 2CMM is the steady-state
Fig. 1. The two-compartment minimal model (2CMM). Capital and
lowercase letters denote variables related to cold and hot glucose,
respectively. See Eqs. 1a–1d for model parameterization details. q1
and q2, hot glucose masses in the first (accessible pool) and second
(slowly equilibrating) compartments, respectively; I8, concentration
of insulin remote from plasma; g, plasma hot glucose concentration;
G, cold glucose concentration in the accessible pool; d, hot glucose
dose; V1, volume of the accessible pool; Rd,0, constant component of
glucose disposal that accounts for inhibition of glucose clearance by
glucose itself; kp, proportionality constant; k21, k12, and k02, glucose
kinetic parameters; and ka, kb, and kc, insulin action parameters.
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plasma clearance rate, which is defined as
plasma clearance rate 0
Rd(t)
G(t) 0ss (8)
Thus, by using Eq. 6, one has
PCR 5 V1 1kp 1 Rd,0V1G 1
k21k02
k02 1 k12 2 (9)
In the following, PCR will be calculated at basal (end
test) glucose concentration, Gb. Note that, in the 2CMM,
PCR is different from glucose effectiveness SG
2* because
the 2CMM explicitly describes the decrease of PCR
when G increases, via the nonzero intercept Rd,0 of the
characteristic (Rd,G). This condition is not true for the
1CMM (3, 7), in which Rd,0 5 0, so that glucose ef-
fectiveness and glucose clearance coincide.
Insulin sensitivity. Insulin sensitivity is defined as
the ability of insulin to enhance glucose effectiveness.
Formally, one has
insulin sensitivity 0 2
­2Rd(t)
­G(t)­I(t) 0ss (10)
where all derivatives are evaluated at the basal (end
test) steady state. When this definition is applied to the
2CMM, insulin sensitivity SI
2* is (see APPENDIX)
SI
2* 5 V1sk
k21k12
(k02 1 k12)2
(11)
Its units (ml·kg21 ·min21 ·µU21 ·ml) are the units of a
clearance (ml·kg21·min21) per unit of insulin concentra-
tion (µU/ml).
The factor sk 5 kakc/kb has an interesting interpreta-
tion: it is a measure of the insulin sensitivity of the
tissues represented by the slowly exchanging glucose
compartment, in which utilization is directly controlled
by insulin. It has the units of a fractional clearance per
unit of insulin concentration (min21 ·µU21 ·ml).
The 2CMM also provides an estimate of total glucose
distribution volume (VD)
VD 5 V1 11 1 k21k02 1 k12 2 (12)
DATABASE AND EXPERIMENTAL PROTOCOL
This study includes 14 stable isotopically labeled
IVGTTs performed on young adults. A bolus of glucose
enriched with [6,6-2H2]glucose was rapidly injected
intravenously at time 0 in all cases except two (subjects
2 and 13), in which [2-2H]glucose was the tracer. Thirty
blood samples were taken at 0, 2, 3, 4, 5, 8, 10, 12, 14,
16, 18, 20, 24, 28, 32, 40, 45, 50, 60, 70, 80, 90, 100, 110,
120, 140, 160, 180, 210, and 240 min. Isotope ratios,
plasma glucose, and insulin were measured (Fig. 2).
The total glucose dose ranged from 0.25 to 0.33 g/kg,
with the tracer being on average 10% of the dose. The
baseline end-test glucose and insulin concentrations
were (means 6 SE) 86 6 2 mg/dl and 9 6 1 µU/ml,
respectively, which were not different from the pretest
values of 88 6 2 mg/dl and 11 6 1 µU/ml, respectively.
Six of these experiments (subjects 1–6) have been
previously analyzed in Ref. 1 with the 1CMM and in
Ref. 8 with the 2CMM for the estimation of endogenous
glucose production. Of the remaining eight experi-
ments, five (subjects 7–11) were obtained at the Depart-
ment of Pediatrics and Medicine, Washington Univer-
sity School of Medicine, St. Louis, Missouri (D. M. Bier,
K. Yarasheski, and J. J. Zachwieja, unpublished data),
and the remaining three (subjects 12–14) at the Center
for Metabolic Diseases, University of Padova, Padua,
Italy (A. Avogaro, unpublished data).
Fig. 2. Mean data for plasma glucose (A), plasma insulin (B), and
isotope ratio (C).
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ESTIMATION OF METABOLIC INDEXES
The model was identified from hot glucose concentra-
tion data, calculated as described in Ref. 1 for subjects
1–6 and in Ref. 2 for subjects 7–14. For a discussion of
the rationale underlying the two approaches, see Refs.
2, 11, and 12. Weighted nonlinear least squares (6) were
used. The measurement error associated with the
tracer measurements was assumed to be independent,
white, and Gaussian, with zero mean and a variance
generated by error propagation from isotope ratio mea-
surement error variance (12). Measurement error coef-
ficient of variation ranged from 2 to 7% on average,
with lower precision associated with lower tracer con-
centrations. Weights were chosen optimally, i.e., equal
to the inverse of the measurement error variance (6).
Model identification was always performed relying on
the whole data set, a method at variance with the
1CMM, in which glucose samples between 0 and 8 min
were neglected to mitigate the single-compartment
approximation. Precision of parameter estimates (for
V1, k21, k12, k02, p2, and sk) was obtained from the inverse
of the Fisher information matrix, whereas that of the
metabolic indexes was obtained by error propagation
(6). For example, if one assumes higher order terms can
be neglected, then the following expression is valid for
the variance of PCR, defined as in Eq. 9
Var(PCR) 5
­(PCR)
­p
Cov[p]
­(PCR)
­p
(13)
where p 5 [V1, k21, k12, k02, p2, sk], partial derivatives
are evaluated at the estimated parameter values, and
Cov(p) is the covariance matrix, i.e., the inverse of the
Fisher information matrix.
The average weighted residuals are shown in Fig. 3
(mean 6 SD) and show no systematic deviations.
In Table 1 parameter estimates of the 2CMM are re-
ported for the 14 subjects, together with their precision.
The calculated total glucose distribution VD is also shown.
The metabolic indexes of the 2CMM are in Table 2.
Their mean values are SG
2* 5 0.85 6 0.14 ml·kg21 ·
min21, PCR 5 2.02 6 0.14 ml·kg21 ·min21, and SI
2* 5
13.83 6 2.54 3 1022 ml·kg21·min21 ·µU21 ·ml. Their mean
precision is 21% for PCR (range 5–65%), 66% for SG
2*
(range 14–231%), and 76% for SI
2* (range 5–401%). SI
2*
and SG
2* precision is unsatisfactory in 3 of 14 subjects.
TWO- VS. SINGLE-COMPARTMENT HOT MINIMAL
MODEL INDEXES
Before the 2CMM and 1CMM indexes are compared,
it is convenient to briefly review the 1CMM and the
indexes it provides.
Fig. 3. Mean weighted residuals for the 2CMM. Shaded zone between 0 and 20 min is enlarged to better visualize
model fitting of data.
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Review of 1CMM. The 1CMM (10), shown in Fig. 4, is
described, in its uniquely identifiable parameteriza-
tion, by
q˙(t) 5 2[p1 1 x(t)]q(t) q(0) 5 d (14a)
x˙(t) 5 2p2x(t) 1 p3[I(t) 2 Ib] x(0) 5 0 (14b)
g(t) 5
q(t)
V
(14c)
where p1, p2, p3, and x relate to k1, k2, k3, k4, and I8 of Fig.
4 as follows: x(t) 5 k4I8(t), p1 5 k1, p2 5 k3, and p3 5 k2k4.
Note that, for the sake of comparison with the 2CMM,
we did not use the superscript asterisk for hot glucose-
related variables, as was done in the original study
(10).
S*G 5 p1 (min21) and S*I 5 p3 /p2 (min21 ·µU21 ·ml)
measure, respectively, fractional (i.e., per unit of glu-
cose distribution volume) glucose effectiveness at basal
insulin and fractional insulin sensitivity, i.e., the abil-
ity of insulin to enhance fractional glucose effective-
ness.
1CMM indexes of glucose effectiveness and insulin
sensitivity with the same units as those derived for the
2CMM can be calculated by directly applying their
definition. They are
­Rd(t)
­G(t) 0ss 5
­[dQ (t)/dt]
­G(t) 0ss 5 S*GV
·(ml·kg21 ·min21)
(15a)
­2Rd(t)
­G(t)­I(t)0ss 5
­2[dQ (t)/dt]
­G(t)­I(t) 0ss 5 S*IV
·(ml·kg21 ·min21)/(µU/ml)
(15b)
By definition, both indexes refer to the same volume of
distribution, i.e., the volume of the accessible pool, V
(and thus of the system because the 1CMM is single
compartment, and therefore the initial and the total
distribution volumes coincide).
At this point, an important difference with the 2CMM
needs to be pointed out. In the 2CMM, glucose effective-
ness SG
2* and plasma clearance rate PCR are different
because of the presence of the inhibitory effect term,
Rd,0 /Q1(t), in Rd (Eq. 6). On the other hand, the 1CMM
does not account for a nonzero Rd,0: it assumes Rd,0 5 0
(glucose disappearance is proportional to glucose con-
centration). In fact, the rate of glucose disappearance of
the 1CMM is given by
Rd(t) 5 [S*G 1 x(t)]Q (t) 5 [S*G 1 x(t)]G(t)V (16)
Table 1. Two-compartment minimal model: parameter estimation results
Subject No.
Estimated Parameters
VD, ml/kg
V1,
ml/kg
k21,
min21
k12,
min21
k02,
min21
p2,
min21
sk,
min21 ·µU21 ·ml
1 124.3 (4) 0.053 (15) 0.040 (31) 0.00299 (45) 0.0253 (86) 0.00050 (43) 277.5
2 139.7 (3) 0.040 (12) 0.031 (29) 0.00296 (28) 0.0411 (107) 0.00027 (30) 306.0
3 154.0 (2) 0.032 (12) 0.024 (40) 0.00396 (88) 0.0097 (341) 0.00051 (341) 330.0
4 151.9 (3) 0.023 (16) 0.013 (75) 0.00255 (116) 0.0218 (580) 0.00018 (170) 375.0
5 130.2 (7) 0.107 (34) 0.172 (30) 0.00541 (10) 0.0851 (16) 0.00068 (11) 208.4
6 128.4 (5) 0.119 (19) 0.100 (23) 0.00281 (7) 0.0927 (14) 0.00140 (10) 277.4
7 143.5 (11) 0.101 (45) 0.111 (45) 0.03376 (9) 0.0889 (22) 0.00140 (13) 270.3
8 145.0 (9) 0.087 (54) 0.152 (76) 0.00381 (27) 0.2285 (82) 0.00281 (48) 225.7
9 156.6 (15) 0.081 (87) 0.112 (112) 0.00532 (13) 0.0723 (29) 0.00370 (41) 264.4
10 108.8 (12) 0.113 (49) 0.155 (48) 0.00442 (13) 0.1248 (62) 0.00157 (17) 185.6
11 133.9 (4) 0.068 (25) 0.084 (49) 0.00373 (17) 0.2358 (177) 0.00190 (34) 238.1
12 139.7 (5) 0.050 (36) 0.038 (83) 0.00400 (15) 0.1894 (116) 0.00040 (110) 304.7
13 154.6 (3) 0.049 (17) 0.048 (22) 0.00401 (8) 0.2738 (464) 0.00113 (40) 299.7
14 128.1 (12) 0.061 (57) 0.036 (119) 0.00376 (10) 0.1183 (77) 0.00093 (178) 325.8
Mean6SE 138.563.7 0.07060.008 0.08060.014 0.0037960.00023 0.114860.0229 0.0012460.00027 277.8613.7
Values are parameter estimates, except total glucose distribution volume (VD), which is calculated. Nos. in parentheses are estimate
precisions expressed as percent coefficient of variation (%CV). V1, volume of the accessible pool; k21, k12, and k02, glucose kinetic parameters; p2
and sk, insulin action parameters.
Table 2. Two-compartment minimal model: metabolic
indexes
Subject
No.
PCR,
ml·kg21 ·min21
SI
2*,
102 ml·kg21 ·
min21 ·µU21 ·ml
SG
2 *,
ml·kg21 ·min21
1 1.83 (22) 7.09 (67) 0.63 (64)
2 1.97 (11) 4.14 (38) 0.87 (25)
3 2.79 (34) 7.67 (401) 1.49 (64)
4 2.27 (34) 3.42 (251) 0.96 (80)
5 1.69 (5) 5.17 (7) 0.61 (14)
6 1.68 (9) 20.33 (5) 0.64 (23)
7 1.71 (11) 17.17 (6) 0.70 (27)
8 1.23 (15) 22.12 (29) 0.08 (231)
9 2.30 (27) 38.13 (10) 1.28 (49)
10 1.36 (8) 11.73 (11) 0.25 (44)
11 1.55 (14) 18.91 (9) 0.20 (109)
12 2.64 (32) 6.02 (71) 1.34 (63)
13 2.33 (9) 15.09 (30) 1.01 (21)
14 2.97 (65) 16.58 (128) 1.84 (105)
Mean6SE 2.0260.14 13.8362.54 0.8560.14
Values are 2-compartment model metabolic index estimates; nos.
in parentheses are estimate precisions (%CV). PCR, plasma clear-
ance rate; SI
2*, insulin sensitivity; SG
2 *, glucose effectiveness.
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When this expression is applied to the definition of
glucose effectiveness (Eq. 5) and the definition of plasma
clearance rate in Eq. 8, it is easy to see that both come
out equal to S*GV. Therefore, for the 1CMM, the esti-
mates of glucose effectiveness and plasma clearance
rate coincide, and both are (by definition) equal to S*GV.
The ability of the 2CMM to single out glucose effective-
ness and insulin sensitivity is therefore unique to the
2CMM.
The 1CMM parameters were estimated from hot
glucose concentration data by weighted nonlinear least
squares, as described in ESTIMATION OF METABOLIC IN-
DEXES. In model identification, glucose samples be-
tween 0 and 8 min were not considered, in order to
mitigate the approximation of the single-compartment
description of glucose kinetics.
The mean weighted residuals of the 1CMM are
shown in Fig. 5. The 1CMM indexes S*GV and S*IV have
been calculated for all subjects and are reported in
Table 3 together with their precision. S*GV was 1.37 6
0.15 ml·kg21 ·min21 (S*G 5 0.74 6 0.04 3 1022 min21),
and S*IV was 12.98 6 2.21 3 1022 ml·kg21 ·min21 ·
µU21 ·ml (S*I 5 6.82 6 0.99 3 1024 min21 ·µU21 ·ml).
Mean precision of the metabolic indexes, calculated via
error propagation (6), was 5% for S*GV (range 2–12%)
and 5% for S*IV (range 3–9%).
At this point, a natural question remains, How do the
1CMM indexes compare with the 2CMM indexes?
Comparison of hot 1CMM and 2CMM indexes. To
compare the 1CMM and 2CMM indexes, we compared
the mean of S*GV vs. either PCR or SG
2* and S*IV vs. SI
2*.
S*GV is significantly lower (P , 0.001) than PCR but
greater (P , 0.001) than SG
2*. S*IV is not different from
SI
2* (NS). If we now compare S*GV vs. SG
2*, S*GV vs. PCR,
and S*IV vs. SI
2* by linear regression, we find that S*GV
correlates weakly with SG
2* (r 5 0.50, NS) and with PCR
(r 5 0.45, NS), whereas S*IV correlates very well with
SI
2* (Fig. 6B) (r 5 0.95, P , 0.001). Notably, the
regression line between S*IV and SI
2* is not different
from the identity line (slope 0.83 6 0.08, P 5 0.05,
intercept 1.55 6 1.31, NS). It is worth noting that, given
this near-perfect correlation and the remarkable preci-
sion with which the 1CMM index is estimated, in case
the two-compartment SI
2* is estimated with unsatisfac-
tory precision, one can use the single-compartment
value, S*IV, instead.
To elucidate the reasons that the comparison of S*GV
with SG
2* and PCR is unsatisfactory, we may usefully
analyze the two components of the product S*GV sepa-
rately. Let us examine S*G, first. S*G is estimated in the
final portion of the tracer disappearance curve and thus
measures the fractional disappearance rate of glucose
when insulin and (cold) glucose concentrations have
almost reached steady state. Under these circum-
stances, the contribution of the fast component of
glucose kinetics and the inhibitory effect of hyperglyce-
mia on glucose clearance have both become negligible.
Fig. 4. The one-compartment minimal model (1CMM). See Eqs.
14a–14c for model parameterization details.
Fig. 5. Mean weighted residuals for the 1CMM. In model identifica-
tion, data between 0 and 8 min are excluded.
Table 3. Single-compartment model indexes
in human subjects
Subject
No.
SG*V,
ml·kg21 ·min21
SI*V,
102 ml·kg21 ·
min21 ·µU21 ·ml
1 1.14 (5) 5.75 (3)
2 1.10 (5) 5.62 (3)
3 1.89 (2) 8.40 (6)
4 0.94 (7) 8.39 (4)
5 1.52 (4) 4.47 (5)
6 1.36 (5) 18.25 (4)
7 1.40 (4) 16.39 (4)
8 1.04 (4) 15.24 (3)
9 1.92 (4) 35.64 (6)
10 1.26 (5) 8.77 (9)
11 1.22 (8) 13.57 (5)
12 1.65 (3) 6.20 (4)
13 1.38 (12) 15.78 (5)
14 1.27 (6) 19.24 (4)
Mean6SE 1.3660.08 12.9862.21
Values are 1-compartment model (1CMM) index estimates; nos. in
parentheses are estimate precisions (%CV). SG*V and SI*V are glucose
effectiveness and insulin sensitivity, respectively, where V is 1CMM
glucose distribution volume.
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As a result, the disappearance of hot glucose is gov-
erned by only the slow component of glucose kinetics,
and the single-pool description of glucose kinetics given
by the 1CMM is in all likelihood accurate. In other
words, in this portion of the IVGTT, the glucose system
behaves like a single-pool system, characterized by a
fractional disappearance rate equal to S*G and a volume
of glucose distribution close to the entire glucose distri-
bution space. Thus the product of S*G and the total
volume of glucose distribution should provide an esti-
mate of basal PCR (not of SG
2*). Because the 1CMM uses
a single compartment to represent the entire glucose
system, the volume V should coincide with the total
volume of glucose distribution and the product S*GV
should measure basal PCR. This, however, does not
occur (S*GV , PCR, as shown above) because V 5 185 6
6 ml/kg is markedly lower than the total glucose
distribution volume (usually 260 ml/kg). When we
multiply S*G by the literature value VD 5 260 ml/kg, the
mean value of S*GV (1.92 ml·kg21 ·min21) becomes quite
close to PCR. However, the correlation remains poor as
before (r 5 0.55, P 5 0.04). A likely explanation for this
outcome is the need for individual estimates of VD. By
normalizing the individual values of PCR using the
corresponding estimate of VD provided by the 2CMM in
each subject (278 6 14 ml/kg on average), one has
PCR/VD 5 0.73 6 0.03 3 1022 min21, which is not
different (NS) from S*G 5 0.74 6 0.04 3 1022 min21. The
correlation (Fig. 6A) is also good (r 5 0.78; P , 0.001),
with the regression line not different from the identity
line (slope 0.88 6 0.21, NS; intercept 0.0010 6 0.0015,
NS). These results again indicate that S*G has the
unequivocal meaning of a fractional clearance rate.
CONCLUSIONS
The hot 2CMM of glucose kinetics provides three new
metabolic indexes: glucose effectiveness (SG
2*), insulin
sensitivity (SI
2*), and plasma clearance rate PCR. These
indexes take into account the fact that glucose kinetics
is more accurately described by a two-compartment
model. When they are compared with the 1CMM in-
dexes, i.e., glucose effectiveness (or plasma clearance
rate) (S*GV) and insulin sensitivity (S*IV), one has that,
although S*IV is very well correlated with SI
2*, S*GV
underestimates PCR and overestimates SG
2* and is
uncorrelated with both. This result is due to the fact
that the 1CMM assumes that glucose disappearance is
proportional to glucose concentration, whereas the
2CMM properly takes into account the inhibitory effect
of glucose on its own clearance. In conclusion, the hot
IVGTT 2CMM, by allowing the derivation, in addition
to endogenous glucose production, of a rich parametric
portrait of glucose disposal, constitutes a powerful tool
to assess glucose metabolism in various physiopathologi-
cal conditions.
APPENDIX
Glucose effectiveness. By applying the definition of glucose
effectiveness to the rate of disappearance of glucose measured
by the 2CMM, one has
SG
2* 5
­Rd(t)
­G(t) 0ss 5 2
­[Q˙1(t)
­G(t) 0ss
5 V1 3kp 1 k21 2 k12 ­Q2(t)­Q1(t)4 0ss
(A1)
Because, from Eq. 1b
Q˙2(t) 5 k21Q1(t) 2 [k02 1 x(t) 1 k12]Q2(t) (A2)
by taking the first derivative of Q˙2(t) with respect to Q1(t), we
have [because ­x(t)/­Q1(t) 5 0]
­Q˙2(t)
­Q1(t)
5 k21 2 [k02 1 x(t) 1 k12]
­Q2(t)
­Q1(t)
(A3)
At steady state
x 5 0 (A4)
and
­Q˙2(t)
­Q1(t) 0ss 5 0 (A5)
Fig. 6. Scatterplot and regression line
of S*G vs. PCR/VD (A) and of S*IV vs. SI
2*
(B). S*G, 1CMM fractional glucose effec-
tiveness (i.e., per unit of glucose distri-
bution volume); PCR, 2CMM plasma
clearance rate; VD, 2CMM total glucose
distribution volume; S*IV, 1CMM insu-
lin sensitivity; SI
2*, 2CMM insulin sen-
sitivity.
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Therefore
k21 2 [k02 1 k12]
­Q2(t)
­Q1(t) 0ss 5 0 (A6)
Rearranging
­Q2(t)
­Q1(t) 0ss 5
k21
k02 1 k12
(A7)
Substituting Eq. A7 into Eq. A1, we have the expression for SG
2*
SG
2* 5 V1 1kp 1 k21k02k02 1 k122 (A8)
Note that for the 2CMM, at variance with the 1CMM, the
accessible pool does not coincide with the system. Thus, in
addition to the glucose disappearance rate from the accessible
pool, it is also possible to calculate the rate of glucose
disappearing from the system, i.e., glucose utilization, U
U(t) 5 3kp 1 Rd,0Q1(t)4Q1(t) 1 [k02 1 x(t)]Q2(t)
5 Rd,0 1 kpQ1(t) 1 [k02 1 x(t)]Q2(t)
(A9)
It is easy to verify that, if one derived glucose effectiveness
from the expression of glucose utilization, thus without
having to refer to the accessible pool only
SG
2* 5
­U(t)
­G(t) 0ss (A10)
then the resulting expression of SG
2* would be the same as in
Eq. A8.
Insulin sensitivity. By applying the definition of insulin
sensitivity to the 2CMM, one has
SI
2* 5
­2[Q˙1(t)]
­G(t)­I(t) 0ss 5 2V1k12
­2[Q2(t)]
­Q1(t)­I(t) 0ss (A11)
Because, from Eq. 1b
Q˙2(t) 5 k21Q1(t) 2 [k02 1 x(t) 1 k12]Q2(t) (A12)
by taking the first derivative of Q˙2(t) with respect to Q1(t), we
have [because ­x(t)/­Q1(t) 5 0]
­Q˙2(t)
­Q1(t)
5 k21 2 [k02 1 x(t) 1 k12]
­Q2(t)
­Q1(t)
(A13)
Rearranging
­Q2(t)
­Q1(t)
5 2
[­Q˙2(t)/­Q1(t)]
k02 1 x(t) 1 k12
1
k21
k02 1 x(t) 1 k12
(A14)
If we take now the derivative of both members of this
equation with respect to I(t), we have
­2Q2(t)
­Q1(t)­I(t)
5 2
­
­I(t) 5
[­Q˙2(t)/­Q1(t)]
k02 1 x(t) 1 k126
1
­
­I(t) 3
k21
k02 1 x(t) 1 k124
(A15)
and
­2Q2(t)
­Q1(t)­I(t)
5 2
­
­I(t) 5
[­Q˙2(t)/­Q1(t)]
k02 1 x(t) 1 k126
2 k21
­[2x˙(t)/p2 1 skI(t)]/­I(t)
[k02 1 x(t) 1 k12]2
(A16)
Because, in steady state, Q˙2 5 0 and x 5 x˙ 5 0, we have
­2Q2(t)
­Q1(t)­I(t) 0ss 5
­2Q2(t)
­I(t)­Q1(t)0ss 5
k21sk
(k02 1 k12)2
(A17)
and substituting in Eq. A11, we have the expression for the
2CMM insulin sensitivity
SI
2* 5 V1sk
k21k12
(k02 1 k12)2
(A18)
This formulation suggests an interesting interpretation of
SI
2*. Provided that sk is the (fractional) insulin sensitivity of
the tissues represented by the slowly exchanging glucose
compartment, in which utilization is directly controlled by
insulin, then SI
2* corresponds to sk multiplied by the volume of
the second compartment ‘‘as seen from’’ the accessible compart-
ment. This representation is better understood by rearrang-
ing Eq. A18 to the form
SI
2* 5 1V1 k21k02 1 k12 2sk
k12
k02 1 k12
(A19)
in which the term in parentheses is the volume of the second
compartment and the last factor is a partition coefficient.
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